ENTO – entero therapeutics inc. (US:NASDAQ)
Stock Stats
News
Entero Therapeutics (NASDAQ:ENTO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Entero Therapeutics (NASDAQ:ENTO) was upgraded by analysts at Wall Stree
Entero Therapeutics (NASDAQ:ENTO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
NF-?B Inhibitors Market to Witness Accelerated Expansion Across the 7MM through 2034 | DelveInsight [Yahoo! Finance]
Form 8-K GridAI Technologies Corp For: Nov 28
Form 10-Q Entero Therapeutics, For: Sep 30
Form NT 10-Q Entero Therapeutics, For: Sep 30
Form SCHEDULE 13G Entero Therapeutics, Filed by: RENAISSANCE TECHNOLOGIES LLC
Form 8-K Entero Therapeutics, For: Oct 17
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.